Exploring the Potential for Tangible Social Technologies for Childhood Cancer Patients within the Hospital

2019 ◽  
Author(s):  
Jillian L. Warren
Keyword(s):  
Childhood Cancer ◽  
Cancer Patients ◽  
Social Technologies

scholarly journals A Systematic Review Summarizing the State of Evidence on Bullying in Childhood Cancer Patients/Survivors

2018 ◽  
Vol 36 (1) ◽  
pp. 55-68 ◽  
Author(s):  
Daisy E. Collins ◽  
Sarah J. Ellis ◽  
Madeleine M. Janin ◽  
Claire E. Wakefield ◽  
Kay Bussey ◽  
...  
Keyword(s):  
General Population ◽  
Childhood Cancer ◽  
Cancer Patients ◽  
The State ◽  
Original Research ◽  
Evidence Based ◽  
Factors Associated ◽  
School Aged Children ◽  
School Absence ◽  
Self Reports

Background: One in four school-aged children is bullied. However, the risk may be greater for childhood cancer patients/survivors (diagnosed <18 years), because of symptoms of the disease and treatment that may prejudice peers. While the serious consequences of bullying are well documented in the general population, bullying may have even greater impact in children with cancer due to the myriad of challenges associated with treatment and prolonged school absence. Objective: To summarize the state of evidence on bullying in childhood cancer patients/survivors; specifically, the rate and types of bullying experienced and the associated factors. Method: We searched five electronic databases from inception to February 2018 for original research articles reporting on bullying in childhood cancer patients/survivors. Results: We identified 29 eligible articles, representing 1,078 patients/survivors ( M = 14.35 years). Self-reports from patients/survivors revealed a considerably higher rate of bullying (32.2%) compared with the general population (25%). Our review identified little information on the factors associated with bullying in patients/survivors. However, the bullying described tended to be verbal and was often related to the physical side effects of treatment, indicating that differences in appearance may prejudice peers. It was further suggested that educating the child’s classmates about cancer may prevent bullying. Conclusions: Our findings confirm that bullying is a significant challenge for many childhood cancer patients/survivors. Additional studies are needed to identify factors that may influence the risk of bullying, which will inform the development of evidence-based interventions and guidelines to prevent bullying in childhood cancer patients/survivors.

Population-based survival for childhood cancer patients diagnosed during 2002-2005 in Shanghai, China

2012 ◽  
Vol 59 (4) ◽  
pp. 657-661 ◽  
Author(s):  
Ping-ping Bao ◽  
Ying Zheng ◽  
Chun-xiao Wu ◽  
Peng Peng ◽  
Yang-ming Gong ◽  
...  
Keyword(s):  
Childhood Cancer ◽  
Cancer Patients ◽  
Population Based

scholarly journals Avascular necrosis of bone in childhood cancer patients: a possible role of genetic susceptibility

2015 ◽  
Vol 116 (05) ◽  
pp. 289-295
Author(s):  
L. Geczova ◽  
A. Soltysova ◽  
J. Gecz ◽  
S. Sufliarska ◽  
J. Horakova ◽  
...  
Keyword(s):  
Childhood Cancer ◽  
Genetic Susceptibility ◽  
Cancer Patients ◽  
Avascular Necrosis ◽  
Avascular Necrosis Of Bone

scholarly journals Anthracycline-Induced Cardiotoxicity in Young Cancer Patients: The Role of Carnitine

2016 ◽  
Vol 68 (Suppl. 3) ◽  
pp. 10-14 ◽  
Author(s):  
Saro H. Armenian
Keyword(s):  
Cancer Survivors ◽  
Childhood Cancer ◽  
Cancer Patients ◽  
Ventricular Remodeling ◽  
Left Ventricular Remodeling ◽  
Childhood Cancer Survivors ◽  
Chronic Health Condition ◽  
Cardiovascular Complications ◽  
Left Ventricular

While the increased rates of survival in childhood cancers have increased progressively in recent decades, many childhood cancer survivors will have at least one chronic health condition within 40 years of age. In this regard, cardiovascular complications have emerged as a leading cause of long-term morbidity and mortality in long-term survivors of childhood cancer, likely due to exposure to anthracycline chemotherapy, and outcomes in patients with anthracycline-related cardiomyopathy remain poor. Some progress has been made in understanding the mechanisms at the basis of anthracycline-related cardiomyopathy, which appear to involve generation of reactive oxygen species, leading to mitochondrial dysfunction, followed by myocyte apoptosis and maladaptive left ventricular remodeling. Even if several guidelines currently exist for monitoring cancer patients treated with cardiotoxic therapies who are at high risk for heart failure, much work remains to be done in finding reliable markers for screening for cardiac dysfunction. Studies from our group have identified alterations in L-carnitine in cancer survivors. While additional investigations are needed, preliminary studies suggest a role for carnitine in primary prevention (during treatment) and secondary prevention (to improve function after treatment).

Varicella in Children With Cancer: Seventy-Seven Case

PEDIATRICS ◽  
1975 ◽  
Vol 56 (3) ◽  
pp. 388-397 ◽  
Author(s):  
Sandor Feldman ◽  
Walter T. Hughes ◽  
C. B. Daniel
Keyword(s):  
Mortality Rate ◽  
General Population ◽  
Childhood Cancer ◽  
Cancer Patients ◽  
Anticancer Therapy ◽  
Children With Cancer ◽  
Acute Encephalitis

The purpose of this study was to characterize varicella in childhood cancer patients. Seventeen of the 77 patients reviewed were in remission and off all therapy for 3 to 22 months. No one in this group died from varicella or had evidence of visceral dissemination. Among the remaining 60 patients, all of whom were receiving anticancer therapy when they developed vancella, 19 (32%) had visceral dissemination and 4 died, for a mortality rate of 7%. Each of the deaths was associated with primary varicella pneumonitis, with or without acute encephalitis. Visceral dissemination was not related to type or status of malignancy or to duration of specific anticancer therapy. Varicella was more likely to disseminate in children with absolute lymphopenia, less than 500 cells per cubic millimeter, than in patients with higher lymphocyte counts. Cessation of anticancer therapy prior to the onset of lesions appeared to lessen the risk of dissemination. These results show that varicella is more severe in cancer patients on therapy than in the general population or in patients who have completed therapy, but is not highly fatal.

Surgery in Childhood Cancer Patients

1982 ◽  
Vol 11 (11) ◽  
pp. 934-944
Author(s):  
Daniel M Hays
Keyword(s):  
Childhood Cancer ◽  
Cancer Patients

scholarly journals Poor Dietary Polyphenol Intake in Childhood Cancer Patients

Nutrients ◽  
2019 ◽  
Vol 11 (11) ◽  
pp. 2835 ◽  
Author(s):  
Ashly Liu ◽  
Jennifer Cohen ◽  
Orazio Vittorio
Keyword(s):  
Childhood Cancer ◽  
Cancer Patients ◽  
Food Sources ◽  
Total Polyphenol ◽  
Nutritional Interventions ◽  
Dietary Recall ◽  
Consumption Data ◽  
Food Consumption Data ◽  
The Mean ◽  
Polyphenol Intake

Emerging research demonstrates polyphenol-rich diets like the Mediterranean diet may play a role in improving the outcomes of adult cancer therapy. To date, there are no trials assessing the intake or efficacy of polyphenol-rich diets in childhood cancer patients. In this study we collected dietary data on 59 childhood cancer patients on treatment using a three-pass 24-h dietary recall (24-HDR), which is based on a validated and structured three-part methodology. Polyphenol consumption was calculated by matching the food consumption data with polyphenol content extracted from the most updated Phenol-Explorer database. The mean total polyphenol intake was 173.31 ± 141.02 mg/day. The major food sources of polyphenols were fruits, beverages, and cereals. There were no significant associations with time since diagnosis, body mass index (BMI) z-score, types of cancer, treatment intensity, food-related symptoms, relapse, and total daily polyphenol intake. Further investigation with larger studies will facilitate the steps in assessing the value of polyphenol-rich dietary patterns in future nutritional interventions for childhood cancer patients.

Sign in / Sign up

Export Citation Format

Share Document